Back to VRTX Stock Lookup

Vertex Pharma (VRTX) – Company Press Releases

Oct 21, 2014 04:47 PM FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation
Oct 14, 2014 04:01 PM Vertex to Announce Third Quarter 2014 Financial Results on October 28
Oct 9, 2014 09:32 AM Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis
Sep 8, 2014 09:00 AM Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014
Sep 2, 2014 04:01 PM Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10
Jul 31, 2014 04:18 PM Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations
Jul 29, 2014 04:01 PM Vertex Reports Second Quarter 2014 Financial Results and Provides Updates on Key Research and Development Programs

Back to VRTX Stock Lookup